Navigation Links
Prime Therapeutics Demonstrates Willingness to Show Actual Pharmacy Costs
Date:10/10/2011

ST. PAUL, Minn., Oct. 10, 2011 /PRNewswire/ -- Prime Therapeutics (Prime), a leading pharmacy benefit manager, has met high standards of pharmacy cost transparency, earning its 2012 Transparency in Pharmaceutical Purchasing Standards(SM) (TIPPS) certification from the HR Policy Association. This is the fifth consecutive year Prime has received this certification.

TIPPS certification is given annually to pharmacy benefit managers (PBMs) that have agreed to provide pharmacy cost information to the association's 60 member companies, who purchase pharmacy benefits for more than five million Americans. Prime was one of just four PBMs that agreed to a set of comprehensive requirements for disclosure of supply costs and revenue sources, and also provided actual average inventory cost (AAIC) for mail service drugs, earning it the HR Policy Association's Tier One Certification for 2012.

"At Prime, we are committed to an approach that integrates medical and pharmacy as well as a philosophy of transparency," said Eric Elliott, president and chief executive officer of Prime. "TIPPS certification continues to be an important recognition for Prime, and we believe that aligning with our clients at mail as well as retail demonstrates our intent to deliver the lowest possible cost of care for clients and their members."

The TIPPS program requires PBMs to provide transparency in reporting acquisition costs, home delivery costs, pass-through of pharmacy revenue, specialty pharmacy drug costs, plan management and consumer engagement efforts. Participating PBMs also grant the association the right to audit the organization in each of these areas. The program's standards promote contracting that makes it easier for employers, their beneficiaries and dependents to understand the true price of a drug and highlight the true value PBMs bring to health care.

Prime Therapeutics is a pharmacy benefit management company dedicated to providing innovative, clinically-based, cost-effective pharmacy solutions for clients and members. Providing pharmacy benefit services nationwide to nearly 17 million covered lives, its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and third-party administrators. Headquartered in St. Paul, Minn., Prime Therapeutics is collectively owned by 12 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans. Learn more at www.primetherapeutics.com.


'/>"/>
SOURCE Prime Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Prime Therapeutics Launches CareCentered Contracting™ Program
2. Wasatch Pediatrics Selects Phreesia and Greenway PrimeSUITE to Streamline its Workflow and Increase Cash Flow
3. Greenways Remote Clinic PrimeMOBILE Available on Apples iPad
4. Prime Therapeutics Drug Trend Insights Reports One of the Lowest Drug Spending Increases in the Industry
5. PrimeraDx Launches the Only System Capable of Simultaneous Quantification of mRNA, microRNA and DNA
6. Prime Therapeutics Announces Pharmacy Offering with Guaranteed Net Spend Per Prescription
7. Michael Showalter Joins Prime Therapeutics As Chief Marketing Officer
8. Prime Therapeutics Vice President of Specialty Pharmacy Solutions Presents at 6th Annual Executive Forum on Pharmacy Benefit Management Strategies
9. Cardinal Health, Prime Therapeutics Renew Primary Distribution Agreement
10. BGI Releases a Complete De Novo E. Coli O104 Genome Assembly and is Making Its Detection Kit Protocols and Synthesized Primers Freely Available to Worldwide Disease Control and Research Agencies
11. TriLink BioTechnologies, Inc. Awarded European Patent for CleanAmp™ Primers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2017)... , April 18, 2017 Cogentix Medical, Inc. ... providing the Urology, Uro/Gyn and Gynecology markets with innovative ... first quarter ended March 31, 2017 after the market ... The Company will host a conference call and webcast ... Tuesday, May 2, 2017 at 4:30 p.m. Eastern Time ...
(Date:4/18/2017)... 18, 2017 Research and Markets has announced ... report to their offering. ... global arthroscopy devices market to grow at a CAGR of 6.35% ... Devices Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
(Date:4/18/2017)... SAN DIEGO and BLOOMINGTON, ... Pharmaceuticals, Inc. (NASDAQ: IMMY ) ("Imprimis"), ... d/b/a Precision Lens ("Precision Lens"), today announced the ... Under the agreement, Precision Lens will deploy a ... into select geographies in the U.S., primarily focused ...
Breaking Medicine Technology:
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... York, NY (PRWEB) , ... April 28, 2017 ... ... Medical Laboratory to expanded distribution of the GlycoMark test throughout the Northeast U.S. ... recent hyperglycemia in patients with diabetes. The GlycoMark test provides a clinically proven ...
(Date:4/28/2017)... ... April 28, 2017 , ... Datta Endoscopic Back Surgery and ... revolutionary endoscopic practice under Dr. Datta. Patel is a Board Certified Anesthesiologist, with ... revolutionary eDiscSculpt Technique created and used by Datta Endoscopic is unlike traditional back ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection ... improve drug safety and minimize the cost of development. In this webinar, sponsored ... using cell lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... pilot study of ActiGraph’s CentrePoint Data Hub in a sample of ... of clinical-grade wearable activity and sleep monitoring solutions for the global scientific community. ...
Breaking Medicine News(10 mins):